跳至主要内容
临床试验/NCT00748787
NCT00748787终止2 期

Multicenter, Double Blind, Randomized, Controlled With Placebo, to Evaluate the Effect of the Treatment With Plantago Ovata Husk in the Incidence of the Remission of Metabolic Syndrome in Children and Adolescents Between 10 to 16 Years Old.

Rottapharm Spain1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
19
试验地点
1
主要终点
Remission of the metabolic syndrome following the IDF criteria for children, it means, waist circumference lower than 90 percentile of the population according to the age.

研究概览

简要总结

The metabolic syndrome represents a constellation of risk factors associated to the abdominal obesity that includes insulin resistance, lipids alterations, high blood pressure etc. Several studies support the hypothesis that the intake of soluble fiber might have a positive effect in the improvement of such of these risk factors.

So that, the aim of this study is to evaluate the efficacy of Ispaghula husk in the remission of metabolic syndrome in children between 10 to 16 years old.

详细描述

The prevalence of the metabolic syndrome is increasing in the last decade as well in adult people as in children and adolescents. The early diagnosis and treatment measures could be very important in order to reduce the cardiovascular risk in such populations.

Ispaghula husk could be efficacious to reach the remission of the syndrome due to its effects in several important lipidic parameters.

The study will consist in the treatment with Ispaghula husk during 4 months in patients with metabolic syndrome. The main variable is the remission of the metabolic syndrome following the IDF(International Diabetes Federation) criteria specifics for children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children between 10 to 16 years old with diagnostic criteria of metabolic syndrome following the IDF criteria:
  • Waist circumference > or equal to percentile 90 according the age.
  • Presence of 2 or more of following factors: systolic blood pressure > or equal 130 mmHg or diastolic > or equal to 85 mmHg, or treated hypertension
  • Cholesterol HDL < 1.03 mmol/l or treatment with drugs to increase cHDL
  • Glucose blood levels > 5.6 mmol/l or type II diabetes diagnosed treated or no.

排除标准

  • Loss of body weight > 3kg in the last 2 months
  • Waist circumference 10 cm higher of 90 percentile according to the age
  • Intake of fiber, aven supplements or phytosterols in the last 2 months
  • Glycosylate haemoglobin >7% in the time of inclusion
  • Systolic blood pressure > 145 mmHg or Diastolic blood pressure >95 mmHg.

研究组 & 干预措施

1

Experimental

干预措施: Ispaghula husk (Drug)

2

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Remission of the metabolic syndrome following the IDF criteria for children, it means, waist circumference lower than 90 percentile of the population according to the age.

时间窗: 16 weeks

次要结局

  • Change in the body weight(16 weeks)
  • Change in the lipid profile(16 weeks)
  • Change in the insulin resistance measured by HOMA index(16 weeks)
  • Change in inflammatory parameters as PCR, IL-6, IL-10, adiponectin(16 weeks)
  • Changes in blood pressure(16 weeks)
  • Tolerability of the treatment(16 weeks)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Trial to Evaluate the Effect of Plantago Ovata Husk... | 临床试验